{"id":"32f0398e-f5d7-41f0-9715-d4db74f9e31e","kind":"companies","code":"UB-C3441","name":"GT Apeiron","nameBasis":"source-english","summary":"Developer of AI innovative drugs.","description":"Pailong Biotech is an innovative drug developer using AI technology","country":"China","category":null,"originalName":"湃隆生物","eventDate":null,"website":"https://www.apeiron-bio.com/","sourceUpdatedAt":"2026-10-03T00:00:00.000Z","englishUpdatedAt":"2026-10-15T20:59:38.229Z","reviewedAt":"2026-10-15T20:59:38.229Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"68b7b1816f7232c7aa11e9f65f6ed8a63e3e56df1c2a6f16f7ecd4e024088ac1","companyId":null,"foundedYear":2019,"logoUrl":null,"originalText":"人工智能创新药物研发商\n\n湃隆生物是一家基于人工智能技术的创新药物研发商","sources":[],"related":[{"id":"224a4d36-3a9e-4b4b-8ed6-9b76efb2ee23","kind":"news","code":"224a4d36-3a9e-4b4b-8ed6-9b76efb2ee23","name":"GT Apeiron raises USD 17.5 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"湃隆生物完成1750万美元A轮融资","eventDate":"2022-03-29T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:38:17.016Z","englishUpdatedAt":"2026-10-15T17:19:59.317Z","reviewedAt":"2026-10-15T17:19:59.317Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"4b64b0850980ed1870dd9f9aa43958fa405b71845a665e65e36d187e6054e961","companyId":"32f0398e-f5d7-41f0-9715-d4db74f9e31e","foundedYear":null,"logoUrl":null,"path":"/news/224a4d36-3a9e-4b4b-8ed6-9b76efb2ee23"},{"id":"2ff19df5-7f66-4201-ae35-63696a7c1c8b","kind":"products","code":"UB-D384","name":"Pailong Biotechnology","nameBasis":"transliterated","summary":"Pailong Biotech develops innovative drugs using AI and emerging biotechnology, aiming to provide effective, safe and clinically practical treatments for difficult diseases. Works with advanced global automated AI drug discovery and other emerging technology platforms on clinically important therapeutic targets, accelerating drug development and optimization. Its initial focus is small-molecule oncology drugs. Targets tumor cell cycles through next-generation CDK inhibitors and uses synthetic lethality to discover anticancer drugs.","description":"Pailong Biotech develops innovative drugs using AI and emerging biotechnology, aiming to provide effective, safe and clinically practical treatments for difficult diseases. Works with advanced global automated AI drug discovery and other emerging technology platforms on clinically important therapeutic targets, accelerating drug development and optimization. Its initial focus is small-molecule oncology drugs. Targets tumor cell cycles through next-generation CDK inhibitors and uses synthetic lethality to discover anticancer drugs.","country":null,"category":"Health management","originalName":"湃隆生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-11T18:07:15.511Z","englishUpdatedAt":"2026-10-16T01:16:54.769Z","reviewedAt":"2026-10-16T01:16:54.769Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f063ed4663d804d63269d1300fc4a149c565cb21af9389ebdc8428740e99fbac","companyId":"32f0398e-f5d7-41f0-9715-d4db74f9e31e","foundedYear":null,"logoUrl":null,"path":"/products/pailongshengwu"},{"id":"d8812c0d-5821-41a0-a182-a3f51a96933e","kind":"institutions","code":"UB-I6347","name":"Panacea Venture","nameBasis":"original-brand","summary":"Panacea Venture is a life sciences venture capital firm.","description":"Panacea Venture is a life sciences venture capital firm.","country":null,"category":null,"originalName":"Panacea Venture","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T17:00:16.031Z","englishUpdatedAt":"2026-10-15T18:21:17.325Z","reviewedAt":"2026-10-15T18:21:17.325Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"239301415b4f0b1a9698e3286cad22b4c13c3172a8c02bf1f7c31b9c81b611f1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/panacea-venture"},{"id":"0c46ead5-ba58-4510-bf93-48625b994639","kind":"institutions","code":"UB-I5764","name":"维亚生物","nameBasis":"transliterated","summary":"Viva Biotech, a biotechnology services company investing in life sciences.","description":"Viva Biotech, a biotechnology services company investing in life sciences.","country":null,"category":null,"originalName":"维亚生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T14:00:14.528Z","englishUpdatedAt":"2026-10-15T20:44:29.300Z","reviewedAt":"2026-10-15T20:44:29.300Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2365654f2634265be20362412e4a0b37198b8f9a175d9e44cdfca7acce8ae755","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Weiya Biotechnology","path":"/institutions/weiya-biotechnology"}],"finance":{"funding":{"metric":"funding","count":1,"latest":{"value":17500000,"text":"1750万美元","date":"2022-03-29T00:00:00.000Z","round":"Series A","estimate":"$17.5M"},"years":[2022],"points":[{"year":2022,"date":"2022-03-29T00:00:00.000Z","round":"Series A","value":17500000,"eventIds":["224a4d36-3a9e-4b4b-8ed6-9b76efb2ee23"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"224a4d36-3a9e-4b4b-8ed6-9b76efb2ee23","date":"2022-03-29T00:00:00.000Z","round":"Series A","amountText":"1750万美元","estimateUsd":17500000,"estimateLabel":"$17.5M","estimateNote":null,"investors":"Panacea Venture,维亚生物","institutions":[{"id":"d8812c0d-5821-41a0-a182-a3f51a96933e","kind":"institutions","code":"UB-I6347","name":"Panacea Venture","nameBasis":"original-brand","summary":"Panacea Venture is a life sciences venture capital firm.","description":"Panacea Venture is a life sciences venture capital firm.","country":null,"category":null,"originalName":"Panacea Venture","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T17:00:16.031Z","englishUpdatedAt":"2026-10-15T18:21:17.325Z","reviewedAt":"2026-10-15T18:21:17.325Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"239301415b4f0b1a9698e3286cad22b4c13c3172a8c02bf1f7c31b9c81b611f1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/panacea-venture"},{"id":"0c46ead5-ba58-4510-bf93-48625b994639","kind":"institutions","code":"UB-I5764","name":"维亚生物","nameBasis":"transliterated","summary":"Viva Biotech, a biotechnology services company investing in life sciences.","description":"Viva Biotech, a biotechnology services company investing in life sciences.","country":null,"category":null,"originalName":"维亚生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T14:00:14.528Z","englishUpdatedAt":"2026-10-15T20:44:29.300Z","reviewedAt":"2026-10-15T20:44:29.300Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2365654f2634265be20362412e4a0b37198b8f9a175d9e44cdfca7acce8ae755","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Weiya Biotechnology","path":"/institutions/weiya-biotechnology"}],"newsUrl":null,"evidence":{"headline":"GT Apeiron raises USD 17.5 million in Series A financing","brief":null,"basis":null,"newsPath":"/news/224a4d36-3a9e-4b4b-8ed6-9b76efb2ee23","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"224a4d36-3a9e-4b4b-8ed6-9b76efb2ee23","date":"2022-03-29T00:00:00.000Z","round":"Series A","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"Panacea Venture,维亚生物","institutions":[{"id":"d8812c0d-5821-41a0-a182-a3f51a96933e","kind":"institutions","code":"UB-I6347","name":"Panacea Venture","nameBasis":"original-brand","summary":"Panacea Venture is a life sciences venture capital firm.","description":"Panacea Venture is a life sciences venture capital firm.","country":null,"category":null,"originalName":"Panacea Venture","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T17:00:16.031Z","englishUpdatedAt":"2026-10-15T18:21:17.325Z","reviewedAt":"2026-10-15T18:21:17.325Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"239301415b4f0b1a9698e3286cad22b4c13c3172a8c02bf1f7c31b9c81b611f1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/panacea-venture"},{"id":"0c46ead5-ba58-4510-bf93-48625b994639","kind":"institutions","code":"UB-I5764","name":"维亚生物","nameBasis":"transliterated","summary":"Viva Biotech, a biotechnology services company investing in life sciences.","description":"Viva Biotech, a biotechnology services company investing in life sciences.","country":null,"category":null,"originalName":"维亚生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T14:00:14.528Z","englishUpdatedAt":"2026-10-15T20:44:29.300Z","reviewedAt":"2026-10-15T20:44:29.300Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2365654f2634265be20362412e4a0b37198b8f9a175d9e44cdfca7acce8ae755","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Weiya Biotechnology","path":"/institutions/weiya-biotechnology"}],"newsUrl":null,"evidence":{"headline":"GT Apeiron raises USD 17.5 million in Series A financing","brief":null,"basis":null,"newsPath":"/news/224a4d36-3a9e-4b4b-8ed6-9b76efb2ee23","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"224a4d36-3a9e-4b4b-8ed6-9b76efb2ee23","kind":"funding","eventDate":"2022-03-29T00:00:00.000Z","revenueDate":null,"round":"A轮","amountText":"1750万美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":17500000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"Panacea Venture,维亚生物","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"d8812c0d-5821-41a0-a182-a3f51a96933e","kind":"institutions","code":"UB-I6347","name":"Panacea Venture","nameBasis":"original-brand","summary":"Panacea Venture is a life sciences venture capital firm.","description":"Panacea Venture is a life sciences venture capital firm.","country":null,"category":null,"originalName":"Panacea Venture","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T17:00:16.031Z","englishUpdatedAt":"2026-10-15T18:21:17.325Z","reviewedAt":"2026-10-15T18:21:17.325Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"239301415b4f0b1a9698e3286cad22b4c13c3172a8c02bf1f7c31b9c81b611f1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/panacea-venture"},{"id":"0c46ead5-ba58-4510-bf93-48625b994639","kind":"institutions","code":"UB-I5764","name":"维亚生物","nameBasis":"transliterated","summary":"Viva Biotech, a biotechnology services company investing in life sciences.","description":"Viva Biotech, a biotechnology services company investing in life sciences.","country":null,"category":null,"originalName":"维亚生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T14:00:14.528Z","englishUpdatedAt":"2026-10-15T20:44:29.300Z","reviewedAt":"2026-10-15T20:44:29.300Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2365654f2634265be20362412e4a0b37198b8f9a175d9e44cdfca7acce8ae755","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Weiya Biotechnology","path":"/institutions/weiya-biotechnology"}],"roundName":"Series A","amountLabel":"$17.5M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[{"id":"2ff19df5-7f66-4201-ae35-63696a7c1c8b","kind":"products","code":"UB-D384","name":"Pailong Biotechnology","nameBasis":"transliterated","summary":"Pailong Biotech develops innovative drugs using AI and emerging biotechnology, aiming to provide effective, safe and clinically practical treatments for difficult diseases. Works with advanced global automated AI drug discovery and other emerging technology platforms on clinically important therapeutic targets, accelerating drug development and optimization. Its initial focus is small-molecule oncology drugs. Targets tumor cell cycles through next-generation CDK inhibitors and uses synthetic lethality to discover anticancer drugs.","description":"Pailong Biotech develops innovative drugs using AI and emerging biotechnology, aiming to provide effective, safe and clinically practical treatments for difficult diseases. Works with advanced global automated AI drug discovery and other emerging technology platforms on clinically important therapeutic targets, accelerating drug development and optimization. Its initial focus is small-molecule oncology drugs. Targets tumor cell cycles through next-generation CDK inhibitors and uses synthetic lethality to discover anticancer drugs.","country":null,"category":"Health management","originalName":"湃隆生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-11T18:07:15.511Z","englishUpdatedAt":"2026-10-16T01:16:54.769Z","reviewedAt":"2026-10-16T01:16:54.769Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f063ed4663d804d63269d1300fc4a149c565cb21af9389ebdc8428740e99fbac","companyId":"32f0398e-f5d7-41f0-9715-d4db74f9e31e","foundedYear":null,"logoUrl":null,"path":"/products/pailongshengwu"}],"investors":[{"id":"d8812c0d-5821-41a0-a182-a3f51a96933e","kind":"institutions","code":"UB-I6347","name":"Panacea Venture","nameBasis":"original-brand","summary":"Panacea Venture is a life sciences venture capital firm.","description":"Panacea Venture is a life sciences venture capital firm.","country":null,"category":null,"originalName":"Panacea Venture","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T17:00:16.031Z","englishUpdatedAt":"2026-10-15T18:21:17.325Z","reviewedAt":"2026-10-15T18:21:17.325Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"239301415b4f0b1a9698e3286cad22b4c13c3172a8c02bf1f7c31b9c81b611f1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/panacea-venture"},{"id":"0c46ead5-ba58-4510-bf93-48625b994639","kind":"institutions","code":"UB-I5764","name":"维亚生物","nameBasis":"transliterated","summary":"Viva Biotech, a biotechnology services company investing in life sciences.","description":"Viva Biotech, a biotechnology services company investing in life sciences.","country":null,"category":null,"originalName":"维亚生物","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T14:00:14.528Z","englishUpdatedAt":"2026-10-15T20:44:29.300Z","reviewedAt":"2026-10-15T20:44:29.300Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"2365654f2634265be20362412e4a0b37198b8f9a175d9e44cdfca7acce8ae755","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Weiya Biotechnology","path":"/institutions/weiya-biotechnology"}],"path":"/companies/pailongshengwu","structured":{"city":"Shanghai","country":"China","location":null,"role":null,"category":null,"company":null},"definition":"GT Apeiron is a company in the Industry apps sector headquartered in Shanghai, China, founded in 2019.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/pailongshengwu"}